Carnivak-Cov was developed by the Federal Center for Animal Health. It is the first in the world and currently the only registered vaccine against the coronavirus for animals.
GlaxoSmithKline will be the most affected, as it represents 26% of the potentially impacted drugs. This is followed by Novartis at 14%, Sanofi at 11%, and both Pfizer and Bayer with 8%.
The FDA evaluated information on the use of a third dose of the Pfizer-BioNTech or Moderna Vaccines and determined that the administration of third vaccine doses may increase protection in this population.
The plant technologists and University teachers took part in the development. It will give a deeper understanding of the organic synthesis manufacturing process and...